Atlas Trials

Prospective Exploratory Study of a Multiomic Blood Biomarker Panel to Predict Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Clinical trial NCT07511569 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07511569
Sponsor
Centre Hospitalier de Bligny
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Chemotherapy Induced Neuropathic PainNeuropathy ToxicTaxane-induced Peripheral NeuropathyOxaliplatin Induced Peripheral Neuropathy in Cancer Patients
Start date
2027-01-04
Primary completion
2029-01-04
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.